Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849559PMC
http://dx.doi.org/10.3324/haematol.2019.226795DOI Listing

Publication Analysis

Top Keywords

novel l-nucleoside
4
l-nucleoside analogue
4
analogue 5-fluorotroxacitabine
4
5-fluorotroxacitabine displays
4
displays potent
4
potent efficacy
4
efficacy acute
4
acute myeloid
4
myeloid leukemia
4
novel
1

Similar Publications

Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing.

Drug Discov Today

July 2022

Center for Advanced Biotechnology and Medicine, and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA. Electronic address:

Infection with HIV can cripple the immune system and lead to AIDS. Hepatitis B virus (HBV) is a hepadnavirus that causes human liver diseases. Both pathogens are major public health problems affecting millions of people worldwide.

View Article and Find Full Text PDF

Fluorinated nucleoside analogues are a major class of cancer chemotherapy agents, and include the drugs 5-fluorouracil (5FU) and 5-fluoro-2'-deoxyuridine (FdUrd). The aim of this study was to examine the cellular toxicity of two novel fluorinated pyrimidine L-nucleosides that are enantiomers of D-nucleosides and may be able to increase selectivity for cancer cells as a result of their unnatural L-configuration. Two fluorinated pyrimidine L-nucleosides were examined in this study, L110 ([β-L, β-D]-5-fluoro-2'-deoxyuridine) and L117 (β-L-deoxyuridine:β-D-5'-fluoro-2'-deoxyuridine).

View Article and Find Full Text PDF

Unlabelled: Deoxycytidine kinase (dCK) is a rate-limiting enzyme in the deoxyribonucleoside salvage pathway and a critical determinant of therapeutic activity for several nucleoside analog prodrugs. We have previously reported the development of 1-(2'-deoxy-2'-(18)F-fluoro-beta-D-arabinofuranosyl)cytosine ((18)F-FAC), a new probe for PET of dCK activity in immune disorders and certain cancers. The objective of the current study was to develop PET probes with improved metabolic stability and specificity for dCK.

View Article and Find Full Text PDF

Biotechnological production of L-ribose from L-arabinose.

Appl Microbiol Biotechnol

May 2009

Department of Biotechnology and Chemical Technology, Helsinki University of Technology, PO Box 6100, 02015 Espoo, Finland.

L-Ribose is a rare and expensive sugar that can be used as a precursor for the production of L-nucleoside analogues, which are used as antiviral drugs. In this work, we describe a novel way of producing L-ribose from the readily available raw material L-arabinose. This was achieved by introducing L-ribose isomerase activity into L-ribulokinase-deficient Escherichia coli UP1110 and Lactobacillus plantarum BPT197 strains.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!